Hyderabad, Telangana: As part of its strategy to build a scalable Diagnostics & Healthcare business, Mediciti Institute of Medical Sciences has entered into strategic discussions with Avio Smart Market Stack Limited (formerly Bartronics India Limited) to explore opportunities for research collaboration, clinical validation, and the adoption of advanced molecular diagnostic technologies.
During the engagement, Huwel Lifesciences, the strategic molecular diagnostics partner of Avio Smart Market Stack (ASMS), showcased its portfolio of indigenous diagnostic technologies and ongoing innovations in molecular diagnostics.
The discussions involving Mediciti Institute of Medical Sciences brought together leadership teams, clinicians, researchers, and academic experts to examine how innovative molecular diagnostic solutions can strengthen disease detection, improve clinical decision-making, and enhance healthcare outcomes across India.
Huwel Lifesciences presented its comprehensive portfolio of indigenous molecular diagnostic technologies, covering solutions for tuberculosis, multidrug-resistant tuberculosis (MDR-TB), sepsis, HPV screening, hepatitis, antimicrobial resistance (AMR) detection, respiratory diseases, and environmental surveillance.
The company also highlighted its fully integrated diagnostics platform encompassing assay development, reagent manufacturing, instrumentation, software, and data management to provide scalable and affordable diagnostic solutions for healthcare providers.
The discussions with Mediciti Institute of Medical Sciences focused on collaborative research, clinical validation studies, real-world evidence generation, and opportunities for adopting and deploying Huwel’s diagnostic technologies within Mediciti’s healthcare ecosystem.
The organizations also explored the possibility of pilot programs and product evaluations across selected departments to assess their impact on routine diagnostic workflows.
Recognized for its strong clinical expertise, academic leadership, patient volumes, and research infrastructure, Mediciti Institute of Medical Sciences was identified as a strategic partner capable of supporting scientific collaboration, product evaluation, evidence generation, and future healthcare innovation initiatives.
Vidyasagar Reddy, Managing Director, Avio Smart Market Stack, said: “ASMS has made a significant commitment to building a scalable Diagnostics & Healthcare business through its strategic partnership with Huwel Lifesciences. While scientific validation remains important, our objective is equally focused on accelerating real-world adoption of these technologies by leading healthcare institutions.
The engagement with Mediciti creates opportunities for research collaboration, clinical evaluation, and potential deployment of Huwel’s diagnostic solutions across multiple healthcare applications.”
Dr. Shesheer Kumar, Founder and Director, Huwel Lifesciences, said: “The future of healthcare innovation depends on close collaboration between technology developers, clinicians, and research institutions. Mediciti’s strong research capabilities and clinical expertise make it an ideal partner for advancing scientific validation and evaluating the impact of innovative diagnostics in real-world healthcare settings.
We look forward to exploring opportunities that can contribute to better patient outcomes and stronger healthcare systems, while also supporting wider adoption of advanced molecular diagnostics in routine clinical practice.”
The engagement involving Mediciti Institute of Medical Sciences underscores the growing importance of collaborations between healthcare innovators and academic medical institutions in accelerating the development, validation, adoption, and commercialization of next-generation diagnostic technologies.
It also highlights the increasing role of indigenous healthcare innovations in addressing India’s evolving public health and clinical needs.
As part of its Diagnostics & Healthcare growth strategy, ASMS is actively building market access channels for advanced diagnostic technologies through partnerships with healthcare institutions, government programs, research organizations, and industry stakeholders.
Through its partnership with Huwel Lifesciences, the company aims to accelerate validation, adoption, procurement, and large-scale deployment of indigenous diagnostic solutions across India and international markets.
The strategic discussions with Mediciti Institute of Medical Sciences reflect a shared interest in fostering research collaboration and evaluating innovative molecular diagnostics that could strengthen healthcare delivery and support future scientific advancements.
